These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28652914)

  • 1. Erratum to: Recent advances in capsule-based dry powder inhaler technology.
    Lavorini F; Pistolesi M; Usmani OS
    Multidiscip Respir Med; 2017; 12():19. PubMed ID: 28652914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the motion of hard-shell capsules in dry powder inhalers.
    Benque B; Khinast JG
    Int J Pharm; 2019 Aug; 567():118481. PubMed ID: 31260784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: Patient Perceptions of Switching to a Generic Dry Powder Inhaler - Increased Understanding Through Journey Mapping [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2381-2382. PubMed ID: 36185171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in capsule-based dry powder inhaler technology.
    Lavorini F; Pistolesi M; Usmani OS
    Multidiscip Respir Med; 2017; 12():11. PubMed ID: 28536654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
    Komase Y; Asako A; Kobayashi A; Sharma R
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction to: Patients' usability of seven most used dry-powder inhalers in COPD.
    Dal Negro RW; Turco P; Povero M
    Multidiscip Respir Med; 2019; 14():39. PubMed ID: 31788243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses.
    Coates MS; Fletcher DF; Chan HK; Raper JA
    Pharm Res; 2005 Jun; 22(6):923-32. PubMed ID: 15948036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs.
    Martinelli F; Balducci AG; Rossi A; Sonvico F; Colombo P; Buttini F
    Int J Pharm; 2015 Jun; 487(1-2):197-204. PubMed ID: 25843756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a cognitive ergonomics approach to compare usability of a multidose dry powder inhaler and a capsule dry powder inhaler: an open-label, randomized, controlled study.
    Franks M; Briggs P
    Clin Ther; 2004 Nov; 26(11):1791-9. PubMed ID: 15639691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a sensitive methodology to characterise hard shell capsule puncture by dry powder inhaler pins.
    Torrisi BM; Birchall JC; Jones BE; Díez F; Coulman SA
    Int J Pharm; 2013 Nov; 456(2):545-52. PubMed ID: 23965433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technological and practical challenges of dry powder inhalers and formulations.
    Hoppentocht M; Hagedoorn P; Frijlink HW; de Boer AH
    Adv Drug Deliv Rev; 2014 Aug; 75():18-31. PubMed ID: 24735675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.
    Sommerfeld M; Cui Y; Schmalfuß S
    Eur J Pharm Sci; 2019 Feb; 128():299-324. PubMed ID: 30553814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend.
    Wauthoz N; Hennia I; Ecenarro S; Amighi K
    Int J Pharm; 2018 Dec; 553(1-2):47-56. PubMed ID: 30321640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses.
    Coates MS; Chan HK; Fletcher DF; Raper JA
    Pharm Res; 2005 Sep; 22(9):1445-53. PubMed ID: 16132356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside.
    Radovanovic D; Santus P; Blasi F; Mantero M
    Multidiscip Respir Med; 2017; 12():17. PubMed ID: 28593046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence logger for a dry powder inhaler: a new device for medical adherence research.
    Bogen D; Apter AJ
    J Allergy Clin Immunol; 2004 Oct; 114(4):863-8. PubMed ID: 15480328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental investigation of design parameters on dry powder inhaler performance.
    Ngoc NT; Chang L; Jia X; Lau R
    Int J Pharm; 2013 Nov; 457(1):92-100. PubMed ID: 24055597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.